Skip to main content
. Author manuscript; available in PMC: 2023 Dec 21.
Published in final edited form as: Hepatology. 2023 Mar 17;77(5):1797–1835. doi: 10.1097/HEP.0000000000000323

TABLE 2.

When to consider testing for less common causes of hepatic steatosis and steatohepatitis

Condition Clinical scenario Diagnostic test Treatment
Hypobetalipoproteinemia Low LDL, low triglycerides, fat malabsorption ApoB level, genetic testing (MTTP, PCSK-9) Low-fat diet, fat-soluble vitamin supplementation
LAL deficiency Markedly elevated LDL-C and low HDL-C, elevated triglycerides, xanthelasma, hypersplenism, advanced fibrosis in young age, predominately microvesicular steatosis on liver biopsy Enzyme assay, genetic testing LAL replacement
Nutrient deficiency (eg, carnitine, choline) Anorexia, short bowel, bypass surgeries Nutrient levels Supplementation
Wilson disease Younger age, neuropsychiatric symptoms, low alkaline phosphatase, low ceruloplasmin 24-h urine copper; quantitative copper on liver biopsy Chelation
Celiac disease Iron deficiency, abdominal pain, bloating, vitamin D deficiency, bone loss, diarrhea, dermatitis herpetiformis Tissue transglutaminase IgA, duodenal biopsy Gluten-free diet

Abbreviations: ApoB, apolipoprotein B; HDL-C, high-density lipoprotein cholesterol; IgA, immunoglobulin A; LAL, lysosomal acid lipase; LDL-C, LDL cholesterol.